Automated insulin delivery: great strides in the past, great needs for the future
Seese R, Boughton CK, Hovorka R
Diabetes Care. Pub. online 24 Jun 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
The effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on lean body mass in humans: a systematic review and meta-analysis of randomised controlled trials
Jobanputra R, Sargeant JA, Plekhanova T, et al.
Diabetes Metab Res Rev. Pub. online 19 Jun 2026.
Leggi
Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis
Gastaldelli A, Scoditti E, Macedo MP
Diabetologia. Pub. online 20 Jun 2026.
Leggi
Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study
McCarthy, A Kent G, Thomas J, et al.
Diabetologia. Pub. online 20 Jun 2026.
Leggi
Continuous Glucose Monitoring (CGM) initiation is associated with reduced mortality in older-onset type 1 diabetes patients: a target trial emulation study within the veterans health administration
Reaven PD, MacwanSA, Kevin McConeghy K, et al.
Diabetes Care. Pub. online 19 Jun 2026.
Leggi
SGLT2 inhibitors for the primary prevention of CKD in type 2 diabetes: a systematic review and meta-analysis
Bannuru RR, Fazioli K, Bhave NM, et al.
Diabetes Obes Cardiometab Care. Pub. online 23 Jun 2026.
Leggi
Longitudinal variability of lipoprotein(a) in youth-onset type 1 diabetes: implications for cardiovascular risk stratification
Iafrate-Luterbacher F, Jimenez-Sanchez C, Anastasiadou ML, et al.
Cardiovasc Diabetol. Pub. online 19 Jun 2026.
Leggi
Women living with diabetes: overlooked and under-recognised, the psychosocial impact
Forde R, Forbes A, Adams D, et al.
Diabet Med. Pub. online 18 Jun 2026.
Leggi
Effects of high-protein diets on renal function and body composition in adults without chronic kidney disease: a systematic review and meta-analysis of randomised trials
Teixeira Silva PR, Santos P, de Miranda Silva Nogueira PA, et al.
Diabetes Obes Metab. Pub. online 14 Jun 2026.
Leggi
Combining sodium–glucose co-transporter-2 inhibitor plus glucagon-like peptide-1 receptor agonist for glucose-lowering in type 2 diabetes: effects of drug initiation sequence on kidney function in real-world clinical practice (CombiKid Study)
Hinton W, Joy M, Forbes AK, et al.
Diabetes Obes Metab. Pub. online 16 Jun 2026.
Leggi